Abstract
Pancreatic cancer poses a challenge in healthcare and is one of a leading cause of cancer-related mortality. In 2021, around 1,000 new cases were diagnosed in Denmark. The disease itself is associated with a poor prognosis. Partly due to its silent nature and partly due to the lack of sensitive and specific tumour markers for early detection. The five-year survival rate among patients with pancreatic cancer in Denmark is 5-6%. I this review, we describe the current diagnostic and treatment options as well as the status on cancer-predictive biomarkers and their screening potential.
| Bidragets oversatte titel | Not Available |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 185 |
| Udgave nummer | 23 |
| ISSN | 0041-5782 |
| Status | Udgivet - 5 jun. 2023 |
Emneord
- Humans
- Early Detection of Cancer
- Pancreatic Neoplasms/diagnosis
- Biomarkers, Tumor
- Prognosis
Fingeraftryk
Dyk ned i forskningsemnerne om 'Pancreatic cancer'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS